- Home
- WSBF vs GNFT Comparison
WSBF vs GNFT Comparison
Compare WSBF & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSBF
- GNFT
- Stock Information
- Founded
- WSBF 1921
- GNFT 1999
- Country
- WSBF United States
- GNFT France
- Employees
- WSBF N/A
- GNFT N/A
- Industry
- WSBF Savings Institutions
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WSBF Finance
- GNFT Health Care
- Exchange
- WSBF Nasdaq
- GNFT Nasdaq
- Market Cap
- WSBF 296.4M
- GNFT 190.6M
- IPO Year
- WSBF N/A
- GNFT 2019
- Fundamental
- Price
- WSBF $13.53
- GNFT $3.75
- Analyst Decision
- WSBF
- GNFT Strong Buy
- Analyst Count
- WSBF 0
- GNFT 1
- Target Price
- WSBF N/A
- GNFT $13.00
- AVG Volume (30 Days)
- WSBF 42.3K
- GNFT 8.9K
- Earning Date
- WSBF 01-28-2025
- GNFT 09-19-2024
- Dividend Yield
- WSBF 4.46%
- GNFT N/A
- EPS Growth
- WSBF 40.34
- GNFT N/A
- EPS
- WSBF 0.71
- GNFT 0.47
- Revenue
- WSBF $133,232,000.00
- GNFT $86,225,222.00
- Revenue This Year
- WSBF N/A
- GNFT $155.44
- Revenue Next Year
- WSBF N/A
- GNFT N/A
- P/E Ratio
- WSBF $19.10
- GNFT $7.55
- Revenue Growth
- WSBF N/A
- GNFT 175.45
- 52 Week Low
- WSBF $10.60
- GNFT $3.31
- 52 Week High
- WSBF $16.86
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- WSBF 25.40
- GNFT 29.68
- Support Level
- WSBF $13.30
- GNFT $3.63
- Resistance Level
- WSBF $14.97
- GNFT $3.94
- Average True Range (ATR)
- WSBF 0.37
- GNFT 0.12
- MACD
- WSBF -0.16
- GNFT 0.03
- Stochastic Oscillator
- WSBF 9.16
- GNFT 0.69
About WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, It operates in two segments: Community Banking and Mortgage Banking. The community banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the community banking segment.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.